Funding for this research was provided by:
Instituto de Salud Carlos III (PI13/125; PI16/0066)
H2020 Marie Skłodowska-Curie Actions (IRG270459)
Fundación Torres (1)
Fundacion Torres (1)
I3 program (IEDI-2015-00638)
Foundation for the National Institutes of Health (BIO13/CI/005)
La Caixa-Caja Navarra Foundation (NA, NA)
Fuerza Julen-Asociación Pablo Ugarte (NA, NA)
"El sueño de Vicky" (NA)
U.S. Department of Defense (CA160525)
US Deparment of Defense (CA160525)
US Department of Defense (CA160525)
American Association for Cancer Research (Grant number 18-40-12-MART)
Received: 20 January 2019
Accepted: 2 April 2019
First Online: 29 April 2019
: Ethical approval for animal studies was granted by the Animal Ethical Committee of the University of Navarra (CEEA; Comité Etico de Experimentación Animal under the protocol number CEEA/069–13). All animal studies were performed in the veterinary facilities of the Center for Applied Medical Research in accordance with institutional, regional, and national laws and ethical guidelines for experimental animal care.
: Not applicable.
: C. Gomez-Manzano and Juan Fueyo report ownership interest (including patents) in and are consultants for DNATrix. M. M. Alonso has a research grant from DNATrix (not related with this manuscript). The remaining authors do not have potential conflicts of interest to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.